Avapritinib

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 263 publications

Systemic Mastocytosis in Adults: 2026 Update on Diagnosis, Risk Stratification and Management.

Systemic Mastocytosis in Adults: 2026 Update on Diagnosis, Risk Stratification and Management.

Journal: American journal of hematology

Published: May 20, 2026

Efficacy and safety analysis of avapritinib in children with RUNX1::RUNX1T1 positive-acute myeloid leukemia with KIT mutations

Efficacy and safety analysis of avapritinib in children with RUNX1::RUNX1T1 positive-acute myeloid leukemia with KIT mutations

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: May 20, 2026

A comprehensive analysis of the adverse drug events of metastatic and unresectable gastrointestinal stromal tumor treatment options: avapritinib, imatinib, regorafenib, ripretinib, and sunitinib safety insights and implications.

A comprehensive analysis of the adverse drug events of metastatic and unresectable gastrointestinal stromal tumor treatment options: avapritinib, imatinib, regorafenib, ripretinib, and sunitinib safety insights and implications.

Journal: Future science OA

Published: May 15, 2026

Sustainable high-throughput microwell spectrophotometric methods for avapritinib quality control via charge-transfer complexation.

Sustainable high-throughput microwell spectrophotometric methods for avapritinib quality control via charge-transfer complexation.

Journal: Scientific reports

Published: March 08, 2026

Comment on "Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study".

Comment on "Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study".

Journal: Journal of the American Academy of Dermatology

Published: March 06, 2026

Machine learning-guided drug repurposing for EGFR inhibition using scaffold-split validation, docking, and molecular dynamics.

Machine learning-guided drug repurposing for EGFR inhibition using scaffold-split validation, docking, and molecular dynamics.

Journal: Journal of computer-aided molecular design

Published: February 27, 2026

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment.

Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment.

Journal: Cancer research communications

Published: January 30, 2026

Journal Club: Mastocytosis: across the spectrum: pathobiology, clinical evaluation, and evolving therapies.

Journal Club: Mastocytosis: across the spectrum: pathobiology, clinical evaluation, and evolving therapies.

Journal: European journal of dermatology : EJD

Published: January 29, 2026

Brugada Phenocopy Associated With the Tyrosine Kinase Inhibitor Avapritinib During Febrile Illness.

Brugada Phenocopy Associated With the Tyrosine Kinase Inhibitor Avapritinib During Febrile Illness.

Journal: JACC. Case reports

Published: January 26, 2026

Skeletal Involvement in Systemic Mastocytosis: Pathophysiology, Clinical Management, Standards of Care, and Novel Therapeutic Strategies.

Skeletal Involvement in Systemic Mastocytosis: Pathophysiology, Clinical Management, Standards of Care, and Novel Therapeutic Strategies.

Journal: Cells

Published: January 15, 2026

Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement.

Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement.

Journal: Annals of hematology

Published: January 15, 2026

Showing 1-12 of 263

Last Updated: 06/30/2026